Isthmus Partners LLC cut its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,030 shares of the company’s stock after selling 139 shares during the period. Isthmus Partners LLC’s holdings in Procter & Gamble were worth $1,737,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the second quarter valued at about $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble during the second quarter worth about $29,000. RPg Family Wealth Advisory LLC bought a new position in shares of Procter & Gamble during the third quarter worth about $33,000. POM Investment Strategies LLC bought a new position in shares of Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble during the second quarter worth about $36,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages have recently commented on PG. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Morgan Stanley increased their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Evercore ISI increased their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Finally, Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $180.45.
Insiders Place Their Bets
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 2.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 35,233 shares of company stock worth $6,024,234. 0.18% of the stock is owned by insiders.
Procter & Gamble Price Performance
NYSE PG opened at $179.36 on Friday. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a market capitalization of $422.40 billion, a PE ratio of 30.92, a P/E/G ratio of 3.86 and a beta of 0.42. The company’s 50 day simple moving average is $170.37 and its 200 day simple moving average is $168.98.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter last year, the business earned $1.83 earnings per share. The business’s revenue for the quarter was down .6% on a year-over-year basis. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.24%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.